Angiodynamics Inc (ANGO): Shareholders' Equity

Annual figures by period end, from SEC filings.

$170.82M
As of 2026-05-31
$163.96M
As of 2026-08-31
-23.3%
3-year compound annual growth
-17.2%
5-year compound annual growth
-10.3%
10-year compound annual growth
$614.82M2010-05-31: $391.35M2011-05-31: $405.64M2012-05-31: $523.31M2013-05-31: $526.32M2014-05-31: $536.88M2014-08-31: $539.59M2014-11-30: $543.24M2015-02-28: $543.57M2015-05-31: $545.10M2015-08-31: $547.18M2015-11-30: $547.73M2016-02-29: $550.80M2016-05-31: $507.23M2017-05-31: $515.03M2018-05-31: $542.60M2019-05-31: $614.82M2020-05-31: $454.87M2021-05-31: $439.46M2022-05-31: $424.49M2023-05-31: $378.30M2024-05-31: $205.59M2025-05-31: $182.97M2026-05-31: $170.82M$170.82M
2010-05-31 Shareholders' Equity (USD) 2026-05-31
Period endedShareholders' EquityChange YoYSource filing
2026-05-31$170.82M-6.6%2026-07-14, Balance as of period end
2025-05-31$182.97M-11.0%2026-07-14, Balance as of period end
2024-05-31$205.59M-45.7%2026-07-14, Balance as of period end
2023-05-31$378.30M-10.9%2025-07-18, Balance as of period end
2022-05-31$424.49M-3.4%2024-07-25, Balance as of period end
2021-05-31$439.46M-3.4%2023-08-03, Balance as of period end
2020-05-31$454.87M-26.0%2022-07-22, Balance as of period end
2019-05-31$614.82M+13.3%2021-07-27, Balance as of period end
2018-05-31$542.60M+5.4%2020-08-10, Balance as of period end
2017-05-31$515.03M+1.5%2019-07-25, Balance as of period end
2016-05-31$507.23Mn/a2018-07-23, Balance as of period end
2016-02-29$550.80Mn/a2016-08-01, Balance as of period end
2015-11-30$547.73Mn/a2016-08-01, Balance as of period end
2015-08-31$547.18Mn/a2016-08-01, Balance as of period end
2015-05-31$545.10Mn/a2017-08-04, Balance as of period end
2015-02-28$543.57Mn/a2016-08-01, Balance as of period end
2014-11-30$543.24Mn/a2016-08-01, Balance as of period end
2014-08-31$539.59Mn/a2016-08-01, Balance as of period end
2014-05-31$536.88M+2.0%2016-08-01, Balance as of period end
2013-05-31$526.32M+0.6%2016-08-01, Balance as of period end
2012-05-31$523.31M+29.0%2016-08-01, Balance as of period end
2011-05-31$405.64M+3.7%2015-01-12, Balance as of period end
2010-05-31$391.35Mn/a2012-08-14, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Angiodynamics Inc (ANGO)2026-05-31$170.82M-6.6%
Tactile Systems Technology Inc (TCMD)2025-12-31$218.90M+1.1%
PROCEPT BioRobotics Corp (PRCT)2025-12-31$365.87M-9.0%
SkinHealth Systems Inc. (SKIN)2025-12-31$61.06M+17.9%
Accuray Inc (ARAY)2026-06-30$41.70M-48.6%
Lemaitre Vascular Inc (LMAT)2025-12-31$393.52M+16.7%
Mimedx Group, Inc. (MDXG)2025-12-31$256.55M+32.9%
Orthopediatrics Corp (KIDS)2025-12-31$346.60M-2.2%
Cerus Corp (CERS)2025-12-31$64.22M+14.4%

Compare ANGO, TCMD, PRCT, SKIN side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗